ID GRSB_BREBE Reviewed; 4450 AA. AC P0C064; P14688; Q44928; DT 05-JUL-2005, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 13-SEP-2023, entry version 74. DE RecName: Full=Gramicidin S synthase 2; DE AltName: Full=Gramicidin S synthase II; DE Includes: DE RecName: Full=ATP-dependent proline adenylase; DE Short=ProA; DE AltName: Full=Proline activase; DE Includes: DE RecName: Full=ATP-dependent valine adenylase; DE Short=ValA; DE AltName: Full=Valine activase; DE Includes: DE RecName: Full=ATP-dependent ornithine adenylase; DE Short=OrnA; DE AltName: Full=Ornithine activase; DE Includes: DE RecName: Full=ATP-dependent leucine adenylase; DE Short=LeuA; DE AltName: Full=Leucine activase; GN Name=grsB; Synonyms=grs2; OS Brevibacillus brevis (Bacillus brevis). OC Bacteria; Bacillota; Bacilli; Bacillales; Paenibacillaceae; Brevibacillus. OX NCBI_TaxID=1393; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=Nagano; RX PubMed=7822255; DOI=10.1093/oxfordjournals.jbchem.a124532; RA Saito F., Hori K., Kanda M., Kurotsu T., Saito Y.; RT "Entire nucleotide sequence for Bacillus brevis Nagano grs2 gene encoding RT gramicidin S synthetase 2; a multifunctional peptide synthetas."; RL J. Biochem. 116:357-367(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-949. RC STRAIN=Nagano; RX PubMed=1939016; DOI=10.1093/oxfordjournals.jbchem.a123528; RA Hori K., Yamamoto Y., Tokita K., Saito F., Kurotsu T., Kanda M., RA Okamura K., Furuyama J., Saito Y.; RT "The nucleotide sequence for a proline-activating domain of gramicidin S RT synthetase 2 gene from Bacillus brevis."; RL J. Biochem. 110:111-119(1991). RN [3] RP PROTEIN SEQUENCE OF 2-16, AND CHARACTERIZATION. RC STRAIN=Nagano; RX PubMed=1917901; DOI=10.1093/oxfordjournals.jbchem.a123454; RA Kurotsu T., Hori K., Kanda M., Saito Y.; RT "Characterization and location of the L-proline activating fragment from RT the multifunctional gramicidin S synthetase 2."; RL J. Biochem. 109:763-769(1991). CC -!- FUNCTION: This protein is a multifunctional enzyme, able to activate CC and polymerize the amino acids Pro, Val, Orn and Leu. Activation sites CC for these AA consist of individual domains. CC -!- COFACTOR: CC Name=pantetheine 4'-phosphate; Xref=ChEBI:CHEBI:47942; CC Note=Binds 4 phosphopantetheines covalently.; CC -!- PATHWAY: Antibiotic biosynthesis; gramicidin S biosynthesis. CC -!- SUBUNIT: Large multienzyme complex of GrsA and GrsB. CC -!- DOMAIN: Consists of four modules, and harbors a putative thioesterase CC domain at its C-terminal end. Each module incorporates one amino acid CC into the peptide product and can be further subdivided into domains CC responsible for substrate adenylation, thiolation, condensation (not CC for the initiation module), and epimerization (optional), and N CC methylation (optional). CC -!- SIMILARITY: Belongs to the ATP-dependent AMP-binding enzyme family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D29676; BAA06146.1; -; Genomic_DNA. DR EMBL; D00938; BAA00778.1; -; Genomic_DNA. DR PIR; JX0340; JX0340. DR PIR; S20542; YGBSG2. DR SMR; P0C064; -. DR ESTHER; bacbr-grsb; Thioesterase. DR UniPathway; UPA00102; -. DR GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW. DR GO; GO:0016874; F:ligase activity; IEA:UniProtKB-KW. DR GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro. DR GO; GO:0043604; P:amide biosynthetic process; IEA:UniProt. DR GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW. DR GO; GO:0019752; P:carboxylic acid metabolic process; IEA:UniProt. DR GO; GO:1901566; P:organonitrogen compound biosynthetic process; IEA:UniProt. DR GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt. DR CDD; cd05930; A_NRPS; 1. DR CDD; cd17650; A_NRPS_PpsD_like; 1. DR CDD; cd17656; A_NRPS_ProA; 1. DR CDD; cd12117; A_NRPS_Srf_like; 1. DR CDD; cd19543; DCL_NRPS; 1. DR CDD; cd19531; LCL_NRPS-like; 3. DR Gene3D; 3.30.300.30; -; 4. DR Gene3D; 3.40.50.980; -; 8. DR Gene3D; 1.10.1200.10; ACP-like; 4. DR Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1. DR Gene3D; 3.30.559.10; Chloramphenicol acetyltransferase-like domain; 4. DR Gene3D; 1.10.287.490; Helix hairpin bin; 1. DR Gene3D; 3.30.559.30; Nonribosomal peptide synthetase, condensation domain; 4. DR InterPro; IPR010071; AA_adenyl_domain. DR InterPro; IPR029058; AB_hydrolase. DR InterPro; IPR036736; ACP-like_sf. DR InterPro; IPR025110; AMP-bd_C. DR InterPro; IPR045851; AMP-bd_C_sf. DR InterPro; IPR020845; AMP-binding_CS. DR InterPro; IPR000873; AMP-dep_Synth/Lig_com. DR InterPro; IPR023213; CAT-like_dom_sf. DR InterPro; IPR001242; Condensatn. DR InterPro; IPR020806; PKS_PP-bd. DR InterPro; IPR009081; PP-bd_ACP. DR InterPro; IPR006162; Ppantetheine_attach_site. DR InterPro; IPR001031; Thioesterase. DR NCBIfam; TIGR01733; AA-adenyl-dom; 4. DR PANTHER; PTHR45527:SF1; FATTY ACID SYNTHASE; 1. DR PANTHER; PTHR45527; NONRIBOSOMAL PEPTIDE SYNTHETASE; 1. DR Pfam; PF00501; AMP-binding; 4. DR Pfam; PF13193; AMP-binding_C; 4. DR Pfam; PF00668; Condensation; 4. DR Pfam; PF00550; PP-binding; 4. DR Pfam; PF00975; Thioesterase; 1. DR SMART; SM00823; PKS_PP; 4. DR SUPFAM; SSF56801; Acetyl-CoA synthetase-like; 4. DR SUPFAM; SSF47336; ACP-like; 4. DR SUPFAM; SSF53474; alpha/beta-Hydrolases; 1. DR SUPFAM; SSF52777; CoA-dependent acyltransferases; 8. DR PROSITE; PS00455; AMP_BINDING; 4. DR PROSITE; PS50075; CARRIER; 4. DR PROSITE; PS00012; PHOSPHOPANTETHEINE; 4. PE 1: Evidence at protein level; KW Antibiotic biosynthesis; Direct protein sequencing; Hydrolase; Ligase; KW Multifunctional enzyme; Phosphopantetheine; Phosphoprotein; Repeat. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:1917901" FT CHAIN 2..4450 FT /note="Gramicidin S synthase 2" FT /id="PRO_0000193088" FT DOMAIN 971..1046 FT /note="Carrier 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" FT DOMAIN 2006..2081 FT /note="Carrier 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" FT DOMAIN 3051..3126 FT /note="Carrier 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" FT DOMAIN 4089..4164 FT /note="Carrier 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" FT REGION 467..1044 FT /note="Domain 1 (proline-activating)" FT /evidence="ECO:0000250" FT REGION 1521..2080 FT /note="Domain 2 (valine-activating)" FT /evidence="ECO:0000250" FT REGION 2538..3134 FT /note="Domain 3 (ornithine-activating)" FT /evidence="ECO:0000250" FT REGION 3590..4172 FT /note="Domain 4 (leucine-activating)" FT /evidence="ECO:0000250" FT MOD_RES 1006 FT /note="O-(pantetheine 4'-phosphoryl)serine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" FT MOD_RES 2041 FT /note="O-(pantetheine 4'-phosphoryl)serine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" FT MOD_RES 3086 FT /note="O-(pantetheine 4'-phosphoryl)serine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" FT MOD_RES 4124 FT /note="O-(pantetheine 4'-phosphoryl)serine" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258" SQ SEQUENCE 4450 AA; 508684 MW; F3197E77BF69316D CRC64; MSTFKKEHVQ DMYRLSPMQE GMLFHALLDK DKNAHLVQMS IAIEGIVDVE LLSESLNILI DRYDVFRTTF LHEKIKQPLQ VVLKERPVQL QFKDISSLDE EKREQAIEQY KYQDGETVFD LTRDPLMRVA IFQTGKVNYQ MIWSFHHILM DGWCFNIIFN DLFNIYLSLK EKKPLQLEAV QPYKQFIKWL EKQDKQEALR YWKEHLMNYD QSVTLPKKKA AINNTTYEPA QFRFAFDKVL TQQLLRIANQ SQVTLNIVFQ TIWGIVLQKY NSTNDVVYGS VVSGRPSEIS GIEKMVGLFI NTLPLRIQTQ KDQSFIELVK TVHQNVLFSQ QHEYFPLYEI QNHTELKQNL IDHIMVIENY PLVEELQKNS IMQKVGFTVR DVKMFEPTNY DMTVMVLPRD EISVRLDYNA AVYDIDFIRK IEGHMKEVAL CVANNPHVLV QDVPLLTKQE KQHLLVELHD SITEYPDKTI HQLFTEQVEK TPEHVAVVFE DEKVTYRELH ERSNQLARFL REKGVKKESI IGIMMERSVE MIVGILGILK AGGAFVPIDP EYPKERIGYM LDSVRLVLTQ RHLKDKFAFT KETIVIEDPS ISHELTEEID YINESEDLFY IIYTSGTTGK PKGVMLEHKN IVNLLHFTFE KTNINFSDKV LQYTTCSFDV CYQEIFSTLL SGGQLYLIRK ETQRDVEQLF DLVKRENIEV LSFPVAFLKF IFNEREFINR FPTCVKHIIT AGEQLVVNNE FKRYLHEHNV HLHNHYGPSE THVVTTYTIN PEAEIPELPP IGKPISNTWI YILDQEQQLQ PQGIVGELYI SGANVGRGYL NNQELTAEKF FADPFRPNER MYRTGDLARW LPDGNIEFLG RADHQVKIRG HRIELGEIEA QLLNCKGVKE AVVIDKADDK GGKYLCAYVV MEVEVNDSEL REYLGKALPD YMIPSFFVPL DQLPLTPNGK IDRKSLPNLE GIVNTNAKYV VPTNELEEKL AKIWEEVLGI SQIGIQDNFF SLGGHSLKAI TLISRMNKEC NVDIPLRLLF EAPTIQEISN YINGAKKESY VAIQPVPEQE YYPVSSVQKR MFILNEFDRS GTAYNLPGVM FLDGKLNYRQ LEAAVKKLVE RHEALRTSFH SINGEPVQRV HQNVELQIAY SESTEDQVER IIAEFMQPFA LEVAPLLRVG LVKLEAERHL FIMDMHHIIS DGVSMQIMIQ EIADLYKEKE LPTLGIQYKD FTVWHNRLLQ SDVIEKQEAY WLNVFTEEIP VLNLPTDYPR PTIQSFDGKR FTFSTGKQLM DDLYKVATET GTTLYMVLLA AYNVFLSKYS GQDDIVVGTP IAGRSHADVE NMLGMFVNTL AIRSRLNNED TFKDFLANVK QTALHAYENP DYPFDTLVEK LGIQRDLSRN PLFDTMFVLQ NTDRKSFEVE QITITPYVPN SRHSKFDLTL EVSEEQNEIL LCLEYCTKLF TDKTVERMAG HFLQILHAIV GNPTIIISEI EILSEEEKQH ILFEFNDTKT TYPHMQTIQG LFEEQVEKTP DHVAVGWKDQ ALTYRELNER ANQVARVLRQ KGVQPDNIVG LLVERSPEML VGIMGILKAG GAYLPLDPEY PADRISYMIQ DCGVRIMLTQ QHLLSLVHDE FDCVILDEDS LYKGDSSNLA PVNQAGDLAY IMYTSGSTGK PKGVMVEHRN VIRLVKNTNY VQVREDDRII QTGAIGFDAL TFEVFGSLLH GAELYPVTKD VLLDAEKLHK FLQANQITIM WLTSPLFNQL SQGTEEMFAG LRSLIVGGDA LSPKHINNVK RKCPNLTMWN GYGPTENTTF STCFLIDKEY DDNIPIGKAI SNSTVYIMDR YGQLQPVGVP GELCVGGDGV ARGYMNQPAL TEEKFVPNPF APGERMYRTG DLARWLPDGT IEYLGRIDQQ VKIRGYRIEP GEIETLLVKH KKVKESVIMV VEDNNGQKAL CAYYVPEEEV TVSELREYIA KELPVYMVPA YFVQIEQMPL TQNGKVNRSA LPKPDGEFGT ATEYVAPSSD IEMKLAEIWH NVLGVNKIGV LDNFFELGGH SLRAMTMISQ VHKEFDVELP LKVLFETPTI SALAQYIADG EKGMYLAIQP VTPQDYYPVS SAQKRMYILY EFEGAGITYN VPNVMFIEGK LDYQRFEYAI KSLINRHEAL RTSFYSLNGE PVQRVHQNVE LQIAYSEAKE DEIEQIVESF VQPFDLEIAP ALRVGLVKLA SDRHLFLMDM HHIISDGVSM QIITKEIADL YKGKELAELH IQYKDFAVWQ NEWFQSAALE KQKTYWLNTF AEDIPVLNLS TDYPRPTIQS FEGDIVTFSA GKQLAEELKR LATETGTTLY MLLLAAYNVL LHKYSGQEEI VVGTPIAGRS HADVENIVGM FVNTLALKNT PIAVRTFHEF LLEVKQNALE AFENQDYPFE NLIEKLQVRR DLSRNPLFDT MFSLSNIDEQ VEIGIEGLSF SPYEMQYWIA KFDISFDILE KQDDIQFYFN YCTNLFKKET IERLATHFMH ILQEIVINPE IKLCEINMLS EEEQQRVLYD FNGTDATYAT NKIFHELFEE QVEKTPDHIA VIDEREKLSY QELNAKANQL ARVLRQKGVQ PNSMVGIMVD RSLDMIVGML GVLKAGGAYV PIDIDYPQER ISYMMEDSGA ALLLTQQKLT QQIAFSGDIL YLDQEEWLHE EASNLEPIAR PQDIAYIIYT SGTTGKPKGV MIEHQSYVNV AMAWKDAYRL DTFPVRLLQM ASFAFDVSAG DFARALLTGG QLIVCPNEVK MDPASLYAII KKYDITIFEA TPALVIPLME YIYEQKLDIS QLQILIVGSD SCSMEDFKTL VSRFGSTIRI VNSYGVTEAC IDSSYYEQPL SSLHVTGTVP IGKPYANMKM YIMNQYLQIQ PVGVIGELCI GGAGVARGYL NRPDLTAEKF VPNPFVPGEK LYRTGDLARW MPDGNVEFLG RNDHQVKIRG IRIELGEIEA QLRKHDSIKE ATVIAREDHM KEKYLCAYMV TEGEVNVAEL RAYLATDLPA AMIPSYFVSL EAMPLTANGK IDKRSLPEPD GSISIGTEYV APRTMLEGKL EEIWKDVLGL QRVGIHDDFF TIGGHSLKAM AVISQVHKEC QTEVPLRVLF ETPTIQGLAK YIEETDTEQY MAIQPVSGQD YYPVSSAQKR MFIVNQFDGV GISYNMPSIM LIEGKLERTR LESAFKRLIE RHESLRTSFE IINGKPVQKI HEEADFNMSY QVASNEQVEK MIDEFIQPFD LSVAPLLRVE LLKLEEDRHV LIFDMHHIIS DGISSNILMK ELGELYQGNA LPELRIQYKD FAVWQNEWFQ SEAFKKQEEY WVNVFADERP ILDIPTDYPR PMQQSFDGAQ LTFGTGKQLM DGLYRVATET GTTLYMVLLA AYNVLLSKYS GQEDIIVGTP IVGRSHTDLE NIVGMFVNTL AMRNKPEGEK TFKAFVSEIK QNALAAFENQ DYPFEELIEK LEIQRDLSRN PLFDTLFSLQ NIGEESFELA ELTCKPFDLV SKLEHAKFDL SLVAVEKEEE IAFGLQYCTK LYKEKTVEQL AQHFIQIVKA IVENPDVKLS DIDMLSEEEK KQIMLEFNDT KIQYPQNQTI QELFEEQVKK TPEHIAIVWE GQALTYHELN IKANQLARVL REKGVTPNHP VAIMTERSLE MIVGIFSILK AGGAYVPIDP AYPQERIQYL LEDSGATLLL TQSHVLNKLP VDIEWLDLTD EQNYVEDGTN LPFMNQSTDL AYIIYTSGTT GKPKGVMIEH QSIINCLQWR KEEYEFGPGD TALQVFSFAF DGFVASLFAP ILAGATSVLP KEEEAKDPVA LKKLIASEEI THYYGVPSLF SAILDVSSSK DLQNLRCVTL GGEKLPAQIV KKIKEKNKEI EVNNEYGPTE NSVVTTIMRD IQVEQEITIG CPLSNVDVYI VNCNHQLQPV GVVGELCIGG QGLARGYLNK PELTADKFVV NPFVPGERMY KTGDLAKWRS DGMIEYVGRV DEQVKVRGYR IELGEIESAI LEYEKIKEAV VIVSEHTASE QMLCAYIVGE EDVLTLDLRS YLAKLLPSYM IPNYFIQLDS IPLTPNGKVD RKALPEPQTI GLMAREYVAP RNEIEAQLVL IWQEVLGIEL IGITDNFFEL GGHSLKATLL VAKIYEYMQI EMPLNVVFKH STIMKIAEYI THQESENNVH QPILVNVEAD REALSLNGEK QRKNIELPIL LNEETDRNVF LFAPIGAQGV FYKKLAEQIP TASLYGFDFI EDDDRIQQYI ESMIQTQSDG QYVLIGYSSG GNLAFEVAKE MERQGYSVSD LVLFDVYWKG KVFEQTKEEE EENIKIIMEE LRENPGMFNM TREDFELYFA NEFVKQSFTR KMRKYMSFYT QLVNYGEVEA TIHLIQAEFE EEKIDENEKA DEEEKTYLEE KWNEKAWNKA AKRFVKYNGY GAHSNMLGGD GLERNSSILK QILQGTFVVK //